Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine for postoperative analgesia in lower-limb fracture patients
ChiCTR2400093955Phase 4Recruiting
- Sponsor
- Sichuan Provincial Orthopedic Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oliceridine in postoperative pain (2 arms), sponsored by Sichuan Provincial Orthopedic Hospital. Primary endpoints: Nausea and Vomiting. Started Dec 2024; status: recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400093955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093955.